About Us

Our goal is to elucidate the molecular mechanism of myeloid malignancies by investigating the effect of tumor suppressor gene alterations on the pathogenesis of myeloid malignancies utilizing gene-modified mouse models. Read More

SCHOOL OF MEDICINE NEWS

Mount Sinai Researchers Present Studies On Treatment Trends, Myeloma Vaccine, and Predictive Models at Cancer Meeting 
May 17, 2012 - Access to care, vaccine, treatment trends among landmark research at the 2012 American Society of Clinical Oncology meeting.

 

Mount Sinai Prostate Cancer Surgeon Performs 4000th Robotic-Assisted Radical Prostatectomy 
May 15, 2012 - David Samadi, MD, Vice Chairman of Urology, achieved the milestone this spring.

 

Protein Inhibitor Points To Potential Medical Treatments For Skull And Skin Birth Defects 
May 15, 2012 - Mount Sinai researchers have found new clues in the pathogenesis of skull and skin birth defects associated with a rare genetic disorder.

 
VIEW ALL
Contact Us

Mingjiang Xu MD, PhD
Tel: 212-241-2287
Fax: 646-537-8698
Send e-mail

Annenberg Building
1468 Madison Avenue
24th Floor, Room 24-10
Box 1079

Director

Mingjiang Xu MD, PhD

Affiliations
Department of Medicine Division of Hematology/Oncology The Tisch Cancer Institute